                         SEQUENCE LISTING

<110>  ImmunoVaccine Technologies Inc.
 
<120>  Method for Improving the Efficacy of a Survivin Vaccine in the 
       Treatment of Cancer

<130>  78961-124

<160>  14    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Synthetic peptide

<220>
<223>  Survivin peptide SurA1

<220>
<221>  misc_feature
<222>  (1)..(9)
<223>  survivin93-101

<400>  1

Phe Glu Glu Leu Thr Leu Gly Glu Phe 
1               5                   


<210>  2
<211>  9
<212>  PRT
<213>  Synthetic peptide

<220>
<223>  Modified survivin peptide SurA1.T

<400>  2

Phe Thr Glu Leu Thr Leu Gly Glu Phe 
1               5                   


<210>  3
<211>  9
<212>  PRT
<213>  Synthetic peptide

<220>
<223>  Survivin peptide SurA2  

<220>
<221>  misc_feature
<222>  (1)..(9)
<223>  survivin96-104

<400>  3

Leu Thr Leu Gly Glu Phe Leu Lys Leu 
1               5                   


<210>  4
<211>  9
<212>  PRT
<213>  Synthetic peptide

<220>
<223>  Modified survivin peptide SurA2.M

<400>  4

Leu Met Leu Gly Glu Phe Leu Lys Leu 
1               5                   


<210>  5
<211>  10
<212>  PRT
<213>  Synthetic peptide

<220>
<223>  Survivin peptide SurA3

<220>
<221>  misc_feature
<222>  (1)..(10)
<223>  survivin18-27

<400>  5

Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe 
1               5                   10  


<210>  6
<211>  10
<212>  PRT
<213>  Synthetic peptide

<220>
<223>  Modified survivin peptide SurA3.K

<400>  6

Arg Ile Ser Thr Phe Lys Asn Trp Pro Lys 
1               5                   10  


<210>  7
<211>  9
<212>  PRT
<213>  Synthetic peptide

<220>
<223>  Survivin peptide SurA24

<220>
<221>  misc_feature
<222>  (1)..(9)
<223>  survivin20-28

<400>  7

Ser Thr Phe Lys Asn Trp Pro Phe Leu 
1               5                   


<210>  8
<211>  9
<212>  PRT
<213>  Synthetic peptide

<220>
<223>  Survivin peptide SurB7

<220>
<221>  misc_feature
<222>  (1)..(9)
<223>  survivin6-14

<400>  8

Leu Pro Pro Ala Trp Gln Pro Phe Leu 
1               5                   


<210>  9
<211>  16
<212>  PRT
<213>  Synthetic peptide

<220>
<223>  Universal T-helper epitope from tetanus toxoid 

<400>  9

Ala Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu Leu 
1               5                   10                  15      


<210>  10
<211>  429
<212>  DNA
<213>  Homo sapiens

<400>  10
atgggtgccc cgacgttgcc ccctgcctgg cagccctttc tcaaggacca ccgcatctct       60

acattcaaga actggccctt cttggagggc tgcgcctgca ccccggagcg gatggccgag      120

gctggcttca tccactgccc cactgagaac gagccagact tggcccagtg tttcttctgc      180

ttcaaggagc tggaaggctg ggagccagat gacgacccca tagaggaaca taaaaagcat      240

tcgtccggtt gcgctttcct ttctgtcaag aagcagtttg aagaattaac ccttggtgaa      300

tttttgaaac tggacagaga aagagccaag aacaaaattg caaaggaaac caacaataag      360

aagaaagaat ttgaggaaac tgcgaagaaa gtgcgccgtg ccatcgagca gctggctgcc      420

atggattga                                                              429


<210>  11
<211>  142
<212>  PRT
<213>  Homo sapiens

<400>  11

Met Gly Ala Pro Thr Leu Pro Pro Ala Trp Gln Pro Phe Leu Lys Asp 
1               5                   10                  15      


His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly Cys Ala 
            20                  25                  30          


Cys Thr Pro Glu Arg Met Ala Glu Ala Gly Phe Ile His Cys Pro Thr 
        35                  40                  45              


Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys Glu Leu 
    50                  55                  60                  


Glu Gly Trp Glu Pro Asp Asp Asp Pro Ile Glu Glu His Lys Lys His 
65                  70                  75                  80  


Ser Ser Gly Cys Ala Phe Leu Ser Val Lys Lys Gln Phe Glu Glu Leu 
                85                  90                  95      


Thr Leu Gly Glu Phe Leu Lys Leu Asp Arg Glu Arg Ala Lys Asn Lys 
            100                 105                 110         


Ile Ala Lys Glu Thr Asn Asn Lys Lys Lys Glu Phe Glu Glu Thr Ala 
        115                 120                 125             


Lys Lys Val Arg Arg Ala Ile Glu Gln Leu Ala Ala Met Asp 
    130                 135                 140         


<210>  12
<211>  13
<212>  PRT
<213>  Synthetic Peptide

<220>
<223>  Universal T-helper epitope PADRE (pan-DR epitope)

<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa can be any amino acid

<400>  12

Ala Lys Xaa Val Ala Ala Trp Thr Leu Lys Ala Ala Ala 
1               5                   10              


<210>  13
<211>  21
<212>  PRT
<213>  Synthetic Peptide

<220>
<223>  T-helper epitope, tetanus toxoid peptide F21E 

<400>  13

Phe Asn Asn Phe Thr Val Ser Phe Trp Leu Arg Val Pro Lys Val Ser 
1               5                   10                  15      


Ala Ser His Leu Glu 
            20      


<210>  14
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic CpG oligonucleotide

<400>  14
tccatgacgt tcctgacgtt                                                   20


